Mice tumor free and protected from metastases after treatment
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
The scientists tested a 100-year-old idea called in-situ vaccination. The idea is to put something inside a tumor and disrupt the environment that suppresses the immune system, thus allowing the natural defense system to attack the malignancy.
That something–the hard coating of cowpea mosaic virus–caused no detectible side effects, which are a common problem with traditional therapies and some immunotherapies.
The team’s research is published in the journal Nature Nanotechnology.
“The cowpea virus-based nanoparticles act like a switch that turns on the immune system to recognize and fight against the tumor – as well as to remember it,” said Nicole Steinmetz, an assistant professor of biomedical engineering at Case Western Reserve, appointed by the Case Western Reserve School of Medicine.
“The particles are shockingly potent,” said Steven Fiering, professor of microbiology and immunology at Dartmouth’s Geisel School of Medicine. “They’re easy to make and don’t need to carry antigens, drugs or other immunostimmulatory agents on their surface or inside.”
The professors studied the nanoparticles with Dartmouth’s Pat Lizotte, a molecular and cellular biology PhD student; Mee Rie Sheen, a postdoctoral fellow; and Pakdee Rojanasopondist, an undergraduate student; and Case Western Reserve’s Amy Wen, a biomedical engineering PhD student.
Taking another shot
The immune system’s ability to detect and destroy abnormal cells is thought to prevent many cancers, according to the National Cancer Institute. But when tumors start to develop, they can shut down the system, allowing tumors to grow and spread.
To restart immune defenses, the scientists used the tumor itself as if it were the antigen in a vaccine–that is, the target for antibodies produced by the immune system.
The cowpea virus shell, with its infectious components removed, acts as the adjuvant–a substance that triggers and may enhance or prolong antigen-specific immune responses.
The process and results
The researchers first switched on the immune system in mice to attack B16F10 lung melanoma or skin melanoma, leaving the mice tumor-free. When the treated mice were later injected with B16F10 skin melanoma (to re-challenge the cured mice), four out of five mice were soon cancer free and one had a slow-growing tumor.
The nanoparticles proved effective against ovarian, breast and colon tumor models. Most of the tumors deteriorated from the center and collapsed. The systemic response prevented or attacked metastatic disease, which is the deadliest form of cancer.
“You get benefits against disease you don’t even know is there yet,” Fiering said.
“Because everything we do is local, the side effects are limited,” despite the strength and extent of the immune response, Fiering said. No toxicity was found.
Harsh side effects, such as fatigue, pain, flu-like symptoms and more are common with chemo and radiation therapies and with some immunostimulation drugs.
The researchers are now trying to understand how the virus shell stimulates the immune system.
“It’s not cytotoxic, there’s no RNA involved or lipopolysaccharides that may be used as adjuvants, and it’s not simply an irritant,” Steinmetz said. “We see a specific immune response.”
The Latest on: Immune response against cancer
via Google News
The Latest on:Iimmune response against cancer
- Immune system-stimulating nanoparticle could lead to more powerful vaccineson December 3, 2021 at 11:00 am
Researchers designed a new nanoparticle adjuvant that may be more potent than others now in use. Studies in mice showed it significantly improved antibody production following vaccination against HIV, ...
- Do Immune-Based Cancer Drugs Work Better in Men?on December 3, 2021 at 7:09 am
Women are two times more likely than men to die after receiving a combination of cancer immunotherapy drugs called checkpoint inhibitors, but it's not clear if that difference is due to side effects ...
- Activating immune cells for cancer nano-immunotherapyon December 3, 2021 at 6:09 am
With nanotechnology we can understand, mimic, and modulate our immune system. For her Ph.D. research, Annelies Wauters studied how tiny nanocarriers can be used to control the immune system, and ...
- COVID-19 vaccines spur weaker immune response to Delta variant, study findson December 2, 2021 at 10:57 am
Currently available COVID-19 vaccines are less effective against the Delta variant of the virus, still the most common strain in the United States, a study published Thursday by the journal PLOS ...
- Advancing our understanding of T cells to improve cancer therapieson December 2, 2021 at 7:53 am
In this interview, News-Medical talks to Dr. Brendan Horton about his latest research which has shed new light on cancer and T cells.
- SKI Research Reveals New Insights into Immune Response to Viral Infections — Including COVID-19on December 1, 2021 at 9:00 pm
Research from Sloan Kettering Institute immunologists suggests that the body may mount an immune response to respiratory viruses that lasts longer than previously thought. The discovery could impact ...
- Targeting the brain's immune cells may help prevent or treat Alzheimer's diseaseon December 1, 2021 at 12:24 pm
A gene mutation linked to Alzheimer's disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine. The ...
- Study identifies two genes that play key role in protecting ovarian cancer from the immune systemon November 30, 2021 at 6:19 pm
Immunotherapies have shown striking clinical benefit in the treatment of many cancers, especially when used in combination with chemotherapy.
- Scientists identify genes critical to protecting ovarian cancer from the immune systemon November 30, 2021 at 8:11 am
Immunotherapies have shown striking clinical benefit in the treatment of many cancers, especially when used in combination with chemotherapy. However, some cancers respond poorly to immunotherapy, and ...
- Cancer patients hope infusions might enhance protection against Covidon November 29, 2021 at 12:00 pm
Some patients have their eyes on monoclonal antibodies, infusions of coronavirus-fighting antibodies that their own bodies can’t make.
via Bing News